Thursday, April 2, 2026
31.6 C
Bengaluru

MedicinMan Steps into Year Five

MedicinMan August 2015

[wpfilebase tag=file id=50 tpl=download-button /]

Inside this Issue

1. Is Your Field Force Regulation-Proof? by Daxesh Patel

The only way to ride the incoming tide of regulations and guidelines is for pharma to invest in field force learning and development.

2. Leadership Training that Makes a Difference by Gopal Kishore

How to design and deliver a leadership training program that has tangible impact on participants.

3. Catching Them Young by K. Hariram

Grooming the next generation of pharma sales professionals can be taken up by first and second line managers as an ‘industry cause’.

4. Getting Sales Contests Right by Amit Jain

How to design a sales contest that brings in the desired results at the right price.

5. To Coach or Close Sales? by Sunil Bajaj

Many Front-line Managers are too busy chasing sales targets to spend time coaching their MRs for sales excellence. This needs to change.

6. Production Planning for the Brand Manager by Vivek Hattangadi

As sales forecaster, the brand manager plays a very important role in production planning and material management strategy of the company.

Hot this week

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Topics

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...

The Quiet Crisis in the Indian Pharma Field Force

A MedicinMan Editorial based on the Poll framed by...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article